Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients (Q57216686)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 2014

Language	Label	Description	Also known as
English	Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients	scientific article published on 01 November 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

hemodialysis patient

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Hsin-Hung Lin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hung-Hsiang Liou

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Ching-Yuang Lin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Chiu-Ching Huang

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

0 references

publication date

1 November 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

672-678

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hyperphosphatemia of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Role of Klotho in aging, phosphate metabolism, and CKD.

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

How fibroblast growth factor 23 works

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Klotho deficiency causes vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Ten-year experience with sevelamer and calcium salts as phosphate binders.

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Pleiotropic effects of the non-calcium phosphate binder sevelamer.

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Effects of phosphate binders in moderate CKD

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Forging forward with 10 burning questions on FGF23 in kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Laboratory aspects of circulating α-Klotho

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Plasma klotho and cardiovascular disease in adults

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1111%2FNEP.12319

21 January 2018

Identifiers

10.1111/NEP.12319

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25113414%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57216686&oldid=2165210381"